1. Home
  2. PROK vs ATNI Comparison

PROK vs ATNI Comparison

Compare PROK & ATNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • ATNI
  • Stock Information
  • Founded
  • PROK 2015
  • ATNI 1987
  • Country
  • PROK United States
  • ATNI United States
  • Employees
  • PROK 163
  • ATNI N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • ATNI Telecommunications Equipment
  • Sector
  • PROK Health Care
  • ATNI Telecommunications
  • Exchange
  • PROK Nasdaq
  • ATNI Nasdaq
  • Market Cap
  • PROK 212.4M
  • ATNI 240.6M
  • IPO Year
  • PROK N/A
  • ATNI 1991
  • Fundamental
  • Price
  • PROK $1.66
  • ATNI $15.32
  • Analyst Decision
  • PROK Buy
  • ATNI Strong Buy
  • Analyst Count
  • PROK 5
  • ATNI 2
  • Target Price
  • PROK $4.50
  • ATNI $31.00
  • AVG Volume (30 Days)
  • PROK 566.3K
  • ATNI 102.7K
  • Earning Date
  • PROK 11-12-2024
  • ATNI 02-19-2025
  • Dividend Yield
  • PROK N/A
  • ATNI 6.27%
  • EPS Growth
  • PROK N/A
  • ATNI N/A
  • EPS
  • PROK N/A
  • ATNI N/A
  • Revenue
  • PROK N/A
  • ATNI $747,493,000.00
  • Revenue This Year
  • PROK N/A
  • ATNI N/A
  • Revenue Next Year
  • PROK N/A
  • ATNI $1.20
  • P/E Ratio
  • PROK N/A
  • ATNI N/A
  • Revenue Growth
  • PROK N/A
  • ATNI N/A
  • 52 Week Low
  • PROK $1.18
  • ATNI $14.85
  • 52 Week High
  • PROK $4.44
  • ATNI $38.96
  • Technical
  • Relative Strength Index (RSI)
  • PROK 46.29
  • ATNI 32.34
  • Support Level
  • PROK $1.50
  • ATNI $14.90
  • Resistance Level
  • PROK $1.90
  • ATNI $16.85
  • Average True Range (ATR)
  • PROK 0.15
  • ATNI 0.77
  • MACD
  • PROK -0.01
  • ATNI 0.07
  • Stochastic Oscillator
  • PROK 45.45
  • ATNI 20.26

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.

About ATNI ATN International Inc.

ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise US Telecom and International Telecom. The company earns revenue from its telecommunication services.

Share on Social Networks: